10.53
前日終値:
$10.30
開ける:
$10.01
24時間の取引高:
2,488
Relative Volume:
0.12
時価総額:
$6.90M
収益:
-
当期純損益:
$-19.47M
株価収益率:
-0.4125
EPS:
-25.5243
ネットキャッシュフロー:
$-15.57M
1週間 パフォーマンス:
+0.19%
1か月 パフォーマンス:
+3.34%
6か月 パフォーマンス:
-68.38%
1年 パフォーマンス:
-88.38%
Envveno Medical Corporation Stock (NVNO) Company Profile
Compare NVNO vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
NVNO
Envveno Medical Corporation
|
10.53 | 6.90M | 0 | -19.47M | -15.57M | -25.52 |
|
ABT
Abbott Laboratories
|
102.87 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
331.54 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.63 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
62.82 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
81.05 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
Envveno Medical Corporation (NVNO) 最新ニュース
enVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) System - The Clarion-Ledger
enVVeno Medical Shares Crash After FDA Reaffirms VenoValve Rejection - msn.com
Dow Update: Is enVVeno Medical Corporation a strong candidate for buy and holdMarket Trend Report & Consistent Profit Alerts - baoquankhu1.vn
Market Wrap: Whats the MACD signal for enVVeno Medical Corporation2026 Short Interest & Daily Profit Maximizing Tips - baoquankhu1.vn
enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement - thenewsstar.com
enVVeno Medical Corp (NVNO) SEC filings - GuruFocus
enVVeno Medical Corp (NVNO) Stock Earnings Transcripts - GuruFocus
enVVeno Medical Reports FY GAAP EPS of -$33.06 Amid Reverse Stock Split - Intellectia AI
Market Pulse: Whats the MACD signal for enVVeno Medical Corporation2026 Technical Patterns & Weekly Top Gainers Alerts - baoquankhu1.vn
AI Models Reiterate High-Risk, Speculative View on enVVeno Medical (NVNO) - TipRanks
enVVeno Medical reports FY25 EPS ($33.06) vs. ($44.53) last year - TipRanks
EnVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of EnVVe(R) System - 富途牛牛
[10-K] enVVeno Medical Corp Files Annual Report - Stock Titan
enVVeno Medical 10-K: Net loss $19.5M, no revenue, EPS not disclosed - TradingView
5HJ0 Stock Price and Chart — FWB:5HJ0 - TradingView
If You Invested $1,000 in Envveno Medical Corporation (NVNO) - Stock Titan
NVNO's Shares Decline on Unfavorable FDA Review Outcome for VenoValve - MSN
Insider Sell: Francis Duhay Sells Shares of enVVeno Medical Corp (NVNO) - GuruFocus
Director at enVVeno Medical (NVNO) sells 140 shares under Rule 10b5-1 plan - Stock Titan
[144] enVVeno Medical Corp SEC Filing - Stock Titan
Volatility Watch: Is enVVeno Medical Corporation a strong candidate for buy and hold2026 Spike Watch & Safe Capital Preservation Plans - baoquankhu1.vn
enVVeno Medical (NVNO) Stock Analysis Report | Financials & Insights - Benzinga Japan
NorthStrive Fund II LP Calls on enVVeno Medical to Halt Clinical Spending Plans and Call Special Shareholder Meeting to Vote on Strategic Alternatives - The Manila Times
Reviewing Pressure BioSciences (OTCMKTS:PBIO) & enVVeno Medical (NASDAQ:NVNO) - Defense World
NVNO SEC FilingsEnvveno Medical Corporation 10-K, 10-Q, 8-K Forms - Stock Titan
NVNO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Can enVVeno Medical Corporation maintain sales growthQuarterly Profit Summary & Daily Growth Stock Tips - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
enVVeno Medical (NVNO) investor urges halt to trials, strategic review - Stock Titan
enVVeno Medical Announces Reverse Stock Split - Press & Sun-Bulletin
Perceptive funds hold 2.05M enVVeno (NVNO) shares and warrants - Stock Titan
NVNO Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Envveno Medical Corporation (NVNO) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):